Syöpätautien klinikka

Julkaisut 2003
Publications 2003

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Bendardaf R. Prognostic and predictive markers in advanced colorectal carcinoma.
2 Bendardaf R et al. Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma.
3 Bendardaf R et al. Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma.
4 Eskelin S et al. A prognostic model and staging for metastatic uveal melanoma.
5 Haikonen J et al. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
6 Iivanainen E et al. Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor.
7 Junttila TT et al. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: Real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
8 Jyrkkiö S et al. PET-tutkimus syövän hoidon suunnittelussa ja hoitovasteen seurannassa.
9 Kirla RM et al. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
10 Kivelä T et al. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
11 Kumar R et al. BRAF mutations in metastatic melanoma: A possible association with clinical outcome.
12 Lehtiö K. Imaging Perfusion and Hypoxia in Head and Neck Cancer Using Positron Emission Tomography (PET).
13 Lehtiö K et al. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ((18F)FETNIM) and PET using the tumour to plasma ratio.
14 Luukkaa M et al. Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx.
15 Mac Manus MP et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
16 MacManus MP et al. FDG-PET syrjäyttää tietokonetomografian arvioitaessa vastetta ei-pienisoluisen keuhkosyövän kemosädehoitoon.
17 Maula S-M et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
18 Minn H, Knuuti J. PET-tutkimus kliinisessä käytössä.
19 Mouridsen H et al. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group.
20 Ouwehand AC et al. Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa.
21 Pyrhönen S. Täsmälääkkeitä tarvitaan.
22 Pyrhönen S. Syövän hoito kehittyy.
23 Pyrhönen S. Harvinaisten syöpien hoito keskittyy.
24 Räsänen JV et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.
25 Salanterä S et al. Clinical judgement and information seeking by nurses and physicians working with cancer patients.
26 Salminen E. Miten kertoa lapselle, kun äiti sairastuu syöpään.
27 Salminen E et al. Rintasyöpäpotilaan ja puolison odotukset sairauteen liittyvästä tiedonsaannista.
28 Salminen E et al. Androgen deprivation and cognition in prostate cancer.
29 Salminen E et al. Docetaxel with epirubicin-investigations on cardiac safety.
30 Sutinen E et al. Uptake of (N-methyl-11C)alfa-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.
31 Syvanen K et al. Immediate effects of docetaxel alone or in combination with epirubicin on cardiac function in advanced breast cancer.
32 The TAX 326 Study Group et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 Study Group.
33 Utriainen M et al. Evaluation of brain tumor metabolism with [11C] choline PET and 1H-MRS.
34 Vihinen PP et al. Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue.
35 Vihinen PP et al. New prognostic factors and developing therapy of cutaneous melanoma.
36 Yan W et al. Overexpression of Bcl-w in the testis disrupts spermatogenesis: Revelation of a role of BCL-W in male germ cell cycle control.

Julkaisutietokanta 29.9.2004 Publications Data Base 29.9.2004